News

NEWS
Publication
July 27, 2020
InSysBio to evolve its Open Source QSP model of COVID-19
InSysBio has presented a new portion of results in the framework of development of COVID-19 QSP model.
LEARN MORE
NEWS
Press-Release
July 6, 2020
InSysBio to announce the launch of its new tool Heta compiler
Heta compiler has been published on GitHub as an OpenSource (Moscow-06.07.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, presents Heta compiler which is a tool for the development of Quantitative Systems Pharmacology and Systems Biology platforms. Particularly, it allows combining modules written in different formats like: Heta language code, Excel sheets, JSON, YAML formatted structures, SBML and transforming them into the dynamic models of different formats.
LEARN MORE
NEWS
Publication
June 30, 2020
InSysBio to present COVID-19 QSP model further development
InSysBio continues to move forward in COVID-19 QSP model development. Its aim is to describe virus and host cell life cycles, innate and adoptive immune response and possible therapeutic treatments.
LEARN MORE
NEWS
Conference
June 22, 2020
InSysBio team posters to be presented at AACR Virtual Annual Meeting II
AACR Virtual Annual Meeting II has begun! American Association for Cancer Research Annual Meeting is held virtually this year on June 22-24 due to COVID-19 spread. Today InSysBio team's posters were published on AACR website
LEARN MORE
NEWS
Press-Release
June 17, 2020
InSysBio to welcome its new team member Dr. Neil Benson
InSysBio announces the appointment of Dr. Neil Benson as Principal Consultant in area of business development (Edinburgh-Moscow-16.06.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, is proud to announce its new team member Dr. Neil Benson! Dr. Benson has joined InSysBio as Principal Consultant in area of business development of both INSYSBIO LLC and INSYSBIO UK LIMITED. In his capacity as Principal Consultant to InSysBio, he will support further development of the outstanding IO and AD QSP offering of the company.
LEARN MORE
NEWS
Software
June 12, 2020
InSysBio to release the new version of Cytocon DB 1.1.6.4
We are glad to announce the release of the new version of Cytocon DB 1.1.6.4. The DB was significantly extended with new data due to well-coordinated workflow of Cytocon DB team and its new members. Namely, 54 diseases, 24 tissues, 42 molecules, 24 cells and 3701 concentrations were introduced.
LEARN MORE
May 2022
MoTuWeThFrSaSu
      
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1. 24 May 2022 13:04 InSysBio to establish a new legal entity in Cyprus InSysBio announces the creation of a new legal entity INSYSBIO CY Ltd. InSysBio continues the development of its QSP services and QSP tools infrastructure and contributing its experience to global research. Oleg Demin, CEO of InSysBio, comments on the significance and goals of this step.
25
26
27
28
29
30
31
     
Upcoming Events
Tags